Cargando…
Pan-cancer whole-genome comparison of primary and metastatic solid tumours
Metastatic cancer remains an almost inevitably lethal disease(1–3). A better understanding of disease progression and response to therapies therefore remains of utmost importance. Here we characterize the genomic differences between early-stage untreated primary tumours and late-stage treated metast...
Autores principales: | Martínez-Jiménez, Francisco, Movasati, Ali, Brunner, Sascha Remy, Nguyen, Luan, Priestley, Peter, Cuppen, Edwin, Van Hoeck, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247378/ https://www.ncbi.nlm.nih.gov/pubmed/37165194 http://dx.doi.org/10.1038/s41586-023-06054-z |
Ejemplares similares
-
Pan-cancer whole-genome analyses of metastatic solid tumours
por: Priestley, Peter, et al.
Publicado: (2019) -
Pan-cancer landscape of homologous recombination deficiency
por: Nguyen, Luan, et al.
Publicado: (2020) -
Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features
por: Nguyen, Luan, et al.
Publicado: (2022) -
Genetic immune escape landscape in primary and metastatic cancer
por: Martínez-Jiménez, Francisco, et al.
Publicado: (2023) -
Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples
por: Mankor, Joanne M., et al.
Publicado: (2020)